WorldPingRegeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout…
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT
WorldPingA Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S.regulatory approval, capping a three-decade effort…
Brief by WorldPing · Original reporting by STAT
WorldPingGnosis Chain was approved to transition to an EEZ rollup, enabling it to settle directly to Ethereum rather than continue with an independent validator set.
Brief by WorldPing · Original reporting by Cointelegraph
WorldPing